Question 1

What is Day One Biopharmaceuticals Inc (DAWN) stock price today?

Accepted Answer

Day One Biopharmaceuticals Inc (DAWN) currently trades at $21.53 per share. The stock has a market capitalization of $2.22B and a P/E ratio of —x.

Question 2

Is DAWN stock a buy, sell, or hold in 2026?

Accepted Answer

Based on WallStSmart's proprietary analysis, Day One Biopharmaceuticals Inc has a Smart Value Score of 30/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

Question 3

What is Day One Biopharmaceuticals Inc's revenue and earnings?

Accepted Answer

Day One Biopharmaceuticals Inc has trailing twelve-month (TTM) revenue of $158.18M with profit margins of -67.80%. Earnings per share (EPS) is $-1.04.

Question 4

Is DAWN stock overvalued or undervalued?

Accepted Answer

Based on our DCF model, Day One Biopharmaceuticals Inc's intrinsic value is $6.57, representing a margin of safety of -70.93%. The stock currently trades at a P/E of —x.

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$131.16M	$158.18M	$158.18M
Net income	$-132.18M	$-188.92M	$-95.50M	$-107.32M	$-21.28M
EPS	—	—	—	—	$-1.04
Free cash flow	$-109.90M	$-150.08M	$-80.28M	$-104.08M	$-17.65M
Profit margin	—	—	-72.81%	-67.85%	-67.80%

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
DAWN	$2.22B	30	6.3	2.0	4.0	5.0	-70.93%	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Day One Biopharmaceuticals Inc

WallStSmart proprietary scores

Price targets

Price chart

X-Ray snapshot

Key financials

Peer comparison

Smart narrative

Frequently asked questions

Company info

Quick metrics

Performance

Compare